Corvus Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 11/14/2024 | 6.94 M | $36.66 M | 0.00% | 10.41% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 5.56 M | $29.37 M | -6.74% | 8.34% |
| SAMLYN CAPITAL, LLC | 11/14/2024 | 4.53 M | $23.92 M | -26.01% | 6.79% |
| ADAMS STREET PARTNERS LLC | 11/14/2024 | 3.28 M | $17.30 M | 0.00% | 4.91% |
| VANGUARD GROUP INC | 11/13/2024 | 2.42 M | $12.78 M | 46.66% | 3.63% |
| VIVO CAPITAL, LLC | 11/13/2024 | 1.50 M | $7.91 M | 100.00% | 2.24% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 603,877 | $3.19 M | 100.00% | 0.91% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 563,009 | $2.97 M | 22.36% | 0.84% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 500,000 | $2.64 M | 100.00% | 0.75% |
| GHOST TREE CAPITAL, LLC | 11/14/2024 | 500,000 | $2.64 M | 100.00% | 0.75% |
| MORGAN STANLEY | 11/14/2024 | 393,262 | $2.08 M | 5.89% | 0.59% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 386,588 | $2.04 M | -31.45% | 0.58% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 376,121 | $1.99 M | 100.00% | 0.56% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 331,360 | $1.75 M | 100.00% | 0.50% |
| MARSHALL WACE, LLP | 11/14/2024 | 323,211 | $1.71 M | 333.50% | 0.48% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 311,288 | $1.64 M | 52.15% | 0.47% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 218,962 | $1.16 M | 753.65% | 0.33% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 218,300 | $1.15 M | 100.00% | 0.33% |
| STATE STREET CORP | 11/14/2024 | 178,246 | $941,139 | 48.16% | 0.27% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 152,800 | $806,784 | 100.00% | 0.23% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 137,031 | $723,524 | 64.66% | 0.21% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 127,332 | $672,313 | 100.00% | 0.19% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 127,300 | $672,144 | 0.00% | 0.19% |
| TOWERVIEW LLC | 11/06/2024 | 117,500 | $620,400 | -70.63% | 0.18% |
| CITADEL ADVISORS LLC | 11/14/2024 | 97,073 | $512,545 | 83.12% | 0.15% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 79,735 | $420,000 | 100.00% | 0.12% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 71,552 | $377,795 | 49.73% | 0.11% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 63,800 | $336,864 | 100.00% | 0.10% |
| JACKSON SQUARE CAPITAL, LLC | 10/31/2024 | 63,773 | $336,721 | 0.00% | 0.10% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 61,300 | $323,664 | -45.94% | 0.09% |
| CITADEL ADVISORS LLC | 11/14/2024 | 58,900 | $310,992 | 636.25% | 0.09% |
| JANE STREET GROUP, LLC | 11/15/2024 | 50,221 | $265,166 | 100.00% | 0.08% |
| HIKARI POWER LTD | 10/25/2024 | 49,959 | $264,000 | 0.00% | 0.07% |
| JPMORGAN CHASE & CO | 11/08/2024 | 49,556 | $261,656 | 441.48% | 0.07% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 44,400 | $234,432 | 208.33% | 0.07% |
| MISSION WEALTH MANAGEMENT, LP | 10/31/2024 | 40,000 | $211,200 | 100.00% | 0.06% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 37,600 | $198,528 | 152.35% | 0.06% |
| AVITY INVESTMENT MANAGEMENT INC. | 10/10/2024 | 27,580 | $145,622 | 138.17% | 0.04% |
| WOLVERINE TRADING, LLC | 11/14/2024 | 27,500 | $141,625 | 100.00% | 0.04% |
| CITADEL ADVISORS LLC | 11/14/2024 | 25,800 | $136,224 | 67.53% | 0.04% |
| ANCORA ADVISORS, LLC | 11/14/2024 | 23,285 | $122,946 | 100.00% | 0.03% |
| QUINN OPPORTUNITY PARTNERS LLC | 11/13/2024 | 22,327 | $117,887 | 0.00% | 0.03% |
| COMMERCE BANK | 11/08/2024 | 20,000 | $105,600 | 0.00% | 0.03% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 18,208 | $96,138 | -0.22% | 0.03% |
| OPPENHEIMER & CO INC | 11/05/2024 | 16,947 | $89,480 | 100.00% | 0.03% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 16,734 | $88,355 | 3,033.71% | 0.03% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 15,694 | $83,000 | 100.00% | 0.02% |
| UBS GROUP AG | 11/14/2024 | 15,681 | $82,795 | 20.62% | 0.02% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 15,668 | $82,727 | 0.00% | 0.02% |
| WOLVERINE TRADING, LLC | 11/14/2024 | 14,100 | $72,615 | 100.00% | 0.02% |
Corvus Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 82 institutional investors and hedge funds held shares of Corvus Pharmaceuticals, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 6.94 M
Point72 Asset Management, L.P.: 5.56 M
SAMLYN CAPITAL, LLC: 4.53 M
ADAMS STREET PARTNERS LLC: 3.28 M
VANGUARD GROUP INC: 2.42 M
Vivo Capital, LLC: 1.5 M
45.03% of Corvus Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 32.08 M shares in the last 24 months. This purchase volume represents approximately $157.18 M in transactions.